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tut für Pharmakologie und Toxikologie der Universi-
tät Göttingen; Psychiatrische Klinik II der Freien
Universität Berlin
were measured at room temperature in plastic beakers. The
minimum amount of fluid required was 0.5 mL Calibrations were
performed with standard bromide solutions (NaBr suprapur, E.
Merck, Darmstadt) in dist. water before and after each series
of the photometrical gold chloride method (10), which is fairly
specific for bromide and does not measure bromoureides. Normal
values were obtained from patients or volunteers without a
history of bromide or bromoureide intake during the previous 2
months. They had bromide serum levels below the detection limit
of the photometric method (0.5 mmoles/1). The values given are
means and standard deviation (S.D.).
(Eingegangen am 8. November 1973/8. April 1974)
Bromide determination in biological fluids by standard methods
is either time consuming or requires expensive equipment
(1, 2, 3, 4). Ion sensitive electrodes have rarely been used to
determine bromide concentration in biological fluids. The
procedure suggested by Degenhart et al (5) seems to be very
accurate, but is time consuming and requires at least 2 samples
from each patient. Furthermore an individual calibration curve
has to be calculated for each patient by standardized bromide
additions.
The bromide concentration in the serum of normals is below
0.1 mmol/1 (6) and may reach values above 40 mmoles/1 in
patients with bromide intoxication (7). These concentrations
are measurable with bromide electrodes (8). Bromide is libe-
rated during the metabolism of bromoureide hypnotics; a
review of bromoureide metabolism has been given by Beyer (9).
Thus, it should be possible to detect the chronic abuse of
bromide as well as of bromoureides with the same method.
Methods
Bromide-sensitive solid state AgBr/Ag2S electrodes from Orion
(Cambridge, Mass., USA) and from Forschungsinstitut Meins-
berg (DDR) were used together with an Ag/AgCl sleeve type
reference electrode (90-01 Orion).
The reference electrode should show no response to any type
of ion. This ideal situation can only be ensured, however, if
the electrode solution (3 mol/1 KC1) of the reference electrode
can flow out freely. In this respect, the sleeve type electrodes,
which we have used, are superior to any other type. Neither
the stability nor the reproducibility were improved by an electro-
lyte measuring bridge; from this we conclude that possible
diffusion potentials at the junction of the reference electrolyte
and test solution are not a limiting factor in our measurements.
The efflux from the reference electrode could, in theory, inter-
fere with the measurements. However, since only about 0.2
of reference solution flows out ina 5 min measuring period,
the chloride concentration of a 0.5 ml sample would increase
by no more than 2 mmol/1; at physiological chloride concen-
trations of 105 mmol/1, this is negligible.
The measuring chain is independent of pH in the range pH 1-9.
Readings were made in the expanded mV range of a digital pH
meter (701, Orion) after 5 min of stabilization. After each
measurement the electrodes were rinsed with dist. water and
dried with Kleenex tissue. Between measurements the electrodes
were left immersed in bromide solution (1 mmol/1). After each
series of measurements the sensor area was polished with fine
emery paper. Heparinized blood, plasma, serum, saliva or urine
Results and Discussion
The calibration curves with pure bromide solutions were in
agreement with published data (8). The slopes were - 58;0 mV/
decade (Orion) and - 57.8 mV/decade (Meinsberg). 110
mmoles/1 chloride (NaCl suprapur, E. Merck, Darmstadt) gave
an apparent bromide concentration of 0.26 ± 0.03 (N = 10,
Orion) or 0.28 ± 0.04 (N = 10, Meinsberg) mmoles/1. Thus,
chloride interference corresponds to the values reported elsewhere (8).
In the plasma of normals with added bromide (2-40 mmoles/1)
the slopes were - 54.0 mV (Orion) and - 54.5 mV (Meinsberg)
per decade. The apparent bromide concentration in plasma or
serum of normals were 0.53 ± 0.13 (N = 82, Orion) and
0.53 ± 0.15 (N = 201, Meinsberg) mmoles/1. These values are
higher than normal bromide concentrations. They may be
partly explained by interference from chloride (s. above).
Furthermore 0.033 mmoles/1 cysteine (normal plasma concen-
tration according to (11)) gave an apparent bromide concen^
tration of 0.15 ± 0.02 (N = 10, Orion) and 0.13 ± 0.08 (N= 10,
Meinsberg) mmoles/1. Thus, the high apparent bromide concen-
tration in the serum or plasma of normals measured with
electrodes can be explained mainly by interference from
chloride and cysteine, which are present in normal plasma.
From these results it is evident that elevated bromide concen-
trations can only be detected if they are above 1.0 mmoles/1.
This value is outside the 3 S.D. range of both electrodes.
A slow drift to higher bromide Values was observed with alla
biological fluids. With blood, plasma, serum or saliva of nor-
mals fairly stable readings were reached after 2-5 min. If the
bromide concentrations were elevated, stabilization time was
shorter. As shown in figure 1 the correlation between bromide
concentration determined with electrodes and by the photome-·
trie method was good (serum or plasma from patients or
volunteers after ingestion of bromide or bromoureides). To
check the reproducibility serum samples from a severely
bromide intoxicated patient and from a volunteer after in*
gestion of carbromal (l g per day for several weeks) were divided
into 10 parts and measured on different days. The photometri-
cally determined bromide concentrations were 23.3 and 2.1
mmoles/1. With the first sample electrode measurements were
23.3 ± 1.6 (Orion) and 23.5 ±1.7 (Meinsberg) mmoles/1, with
the second one 3.4 ±0.3 (Meinsberg) mmoies/L
With blood from normals the apparent bromide concentrations
measured by electrodes were 0.56 ± 0.10 (N = 34, Orion) and
0.57 ± 0.10 (N = 41, Meinsberg) mrholes/1. The correlation
between electrode measurements in blood and the photometric
bromide determination in the plasma of patients after the
ingestion of bromide or bromoureides was satisfactory (corre-
lation coefficients 0.981 and 0.985, 44 pairs). Thus electrode
measurements in blood give a rather good estimate of bromide
concentration in plasma.
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Fig. 1. Comparison of bromide determination performed with
bromide sensitive electrodes and by a photometric
method. Serum or plasma from patients or volunteers
with elevated bromide concentrations were measured
with both methods.
X = Orion electrode, 31 pairs, r = 0.994
= Meinsberg electrode, 35 pairs, r = 0.992
With saliva from normals the apparent bromide concentrations
with electrodes were 0.22 ± 0.13 (N = 91, Orion) and 0.24
± 0.16 (N = 89, Meinsberg). The molar concentration ratio
bromide/chloride in saliva is higher than in plasma (12). Thus,
in cases with low bromide levels the electrode measurement in
saliva may be preferred. On the other hand, halide concentration
in saliva depends on the flow rate (12). Therefore, bromide
measurements in saliva give only a rough estimate of the
severity of bromide intoxications.
In urine the molar concentration ratio bromide/chloride is
lower than in plasma. Furthermore the bromide excretion
depends on chloride intake..The concentration of interfering
substances in urine (e.g. iodide-or compounds with free SH-
groups) can be much higher than in plasma. For these reasons
bromide determinations in urine with electrodes are expected to
be unreliable. This is reflected by high and variable values in
the urines of normals: 0.80 ± 0.36 (N = 15, Orion) and 0.71
± 0.41 (N = 15, Meinsberg) mmoles/1. Additionally we observed
severe stirring effects and sometimes extreme drifting during
measurement in urine. Thus, electrodes are considered unsui-
table for direct bromide determination in urine.
Acute poisoning with bromoureides cannot be diagnosed with
bromide electrodes since they do not respond to covalently bound
bromine. A serum sample drawn from a patient 3 h after attemp-
ted suicide with carbromal contained 0.6 mmoles/1 bromide
calculated from an electrode reading (0.5 mmoles/1 photometri-
cally) which is within the normal range (mean ± 3 S.D.) of
electrode measurements in serum. After 24 h the concentration
was 1.6 mmoles/1 (1.2 mmoles/1 photometrically). Obviously
it was more than 3 h before enough bromide was liberated from
carbromal to yield detectable bromide levels. The slow meta-
bolic degradation of bromoureides has been described else-
where (9). Determination of bromide concentration with
electrodes in biological fluids can rapidly reveal elevated
bromide concentrations in patients. For more exact, quanti-
tative results one of the standard methods should also be used.
Bromide concentrations below 1 mmol/l, which could not be
detected with electrodes (due to the presence of chloride and
cysteine in normal plasma), are of no clinical relevance (13).
Bromoureide- and bromide-containing drugs are available without
prescription in the Federal Republic of Germany. Abuse of these
drugs is a significant problem (14). Thus, a detection method
suitable for use on the ward or in the outpatient department
may help to reveal cases with elevated bromide levels in body
fluids. The simple procedure of bromide determination with
electrodes described in this paper yields results within a few
minutes.
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